Bristol-Myers Squibb
BMY
#174
Rank
NZ$206.27 B
Marketcap
NZ$101.29
Share price
0.60%
Change (1 day)
3.09%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): NZ$5.12

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$4.96. In 2024 the company made an earnings per share (EPS) of NZ-$7.38 a decrease over its 2023 EPS that were of NZ$6.48.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$5.12-169.35%
2024NZ-$7.38-213.92%
2023NZ$6.4830.2%
2022NZ$4.98-6.04%
2021NZ$5.30-179.29%
2020NZ-$6.68-281.37%
2019NZ$3.68-27.21%
2018NZ$5.06
2016NZ$4.46175.26%
2015NZ$1.62-19.83%
2014NZ$2.02-22.44%
2013NZ$2.6034.48%
2012NZ$1.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.60 275.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.29 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.27-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.99-19.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.44 675.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$23.93 382.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.45-30.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$18.35 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.20 146.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$8.93 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK